Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Prefer HDFC, says Rajat Bose
3.43 pm | 18 Aug 2016 | Source: CNBC-TV18
Rajat Bose of rajatkbose.com is of the view that one may prefer HDFC....
Fund manager's hits and misses from Q1 earnings
4.14 pm | 16 Aug 2016 | Source: CNBC-TV18
In an interview with CNBC-TV18, Rajesh Kothari of AlfAccurate Advisors talked about the hits and misses from the first quarter earnings season, includ...
Cipla appoints Kedar Upadhye as Global CFO
1.10 pm | 01 Aug 2016 | Source: PTI
Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in a statement...
Sell Dr Reddy's; target of Rs 2650: Axis Direct
1.35 pm | 29 Jul 2016 | Source: Moneycontrol.com
Axis Direct is bearish on Dr Reddy's has recommended sell rating on the stock with a target price of Rs 2650, in its research report dated July 27, 20...
Sell Dr Reddys; target of Rs 2800: Religare
12.49 pm | 29 Jul 2016 | Source: Moneycontrol.com
Religare is bearish on Dr Reddys has recommended sell rating on the stock with a target price of Rs 2800 in its research report dated July 27, 2016....
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.